Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN394297 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Poly (ADP-Ribose) Polymerase 1 (PARP1) (AA 1-100) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-100
- Isotype
- IgG
- Antibody clone number
- 3G4
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Lack of association between poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population.
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.
Polymorphisms in the base excision repair pathway and graft-versus-host disease.
Lee KA, Bang SY, Park BL, Kim JH, Shin HD, Bae SC
Rheumatology international 2012 Jan;32(1):91-6
Rheumatology international 2012 Jan;32(1):91-6
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez E
The pharmacogenomics journal 2011 Dec;11(6):437-43
The pharmacogenomics journal 2011 Dec;11(6):437-43
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.
Krishnakumar R, Kraus WL
Molecular cell 2010 Jul 9;39(1):8-24
Molecular cell 2010 Jul 9;39(1):8-24
Polymorphisms in the base excision repair pathway and graft-versus-host disease.
Arora M, Lindgren B, Basu S, Nagaraj S, Gross M, Weisdorf D, Thyagarajan B
Leukemia 2010 Aug;24(8):1470-5
Leukemia 2010 Aug;24(8):1470-5
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA